Solara Active Pharma Sciences Limited

NSEI:SOLARA 주식 보고서

시가총액: ₹26.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Solara Active Pharma Sciences 대차 대조표 상태

재무 상태 기준 확인 1/6

Solara Active Pharma Sciences 의 총 주주 지분은 ₹9.4B 이고 총 부채는 ₹10.0B, 이는 부채 대 자기자본 비율을 106.7% 로 가져옵니다. 총자산과 총부채는 각각 ₹23.5B 및 ₹14.1B 입니다.

주요 정보

106.7%

부채 비율

₹9.99b

부채

이자 보상 비율n/a
현금₹86.00m
주식₹9.37b
총 부채₹14.14b
총 자산₹23.51b

최근 재무 상태 업데이트

Recent updates

Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 32% Solara Active Pharma Sciences Limited (NSE:SOLARA) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

May 11
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Apr 19
Investors Still Aren't Entirely Convinced By Solara Active Pharma Sciences Limited's (NSE:SOLARA) Revenues Despite 28% Price Jump

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Mar 13
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Feb 23
Even With A 26% Surge, Cautious Investors Are Not Rewarding Solara Active Pharma Sciences Limited's (NSE:SOLARA) Performance Completely

Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Jan 04
Further Upside For Solara Active Pharma Sciences Limited (NSE:SOLARA) Shares Could Introduce Price Risks After 25% Bounce

Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

May 12
Solara Active Pharma Sciences Limited's (NSE:SOLARA) Intrinsic Value Is Potentially 81% Above Its Share Price

Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Nov 08
Estimating The Intrinsic Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Sep 30
Is Solara Active Pharma Sciences (NSE:SOLARA) A Risky Investment?

Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Aug 03
Are Investors Undervaluing Solara Active Pharma Sciences Limited (NSE:SOLARA) By 22%?

Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Jun 19
Solara Active Pharma Sciences (NSE:SOLARA) Is Making Moderate Use Of Debt

Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

Feb 17
Newsflash: Solara Active Pharma Sciences Limited (NSE:SOLARA) Analysts Have Been Trimming Their Revenue Forecasts

A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

Dec 21
A Look At The Fair Value Of Solara Active Pharma Sciences Limited (NSE:SOLARA)

With EPS Growth And More, Solara Active Pharma Sciences (NSE:SOLARA) Is Interesting

Oct 28
With EPS Growth And More, Solara Active Pharma Sciences (NSE:SOLARA) Is Interesting

재무 상태 분석

단기부채: SOLARA 의 단기 자산 ( ₹8.0B )은 단기 부채( ₹12.4B ).

장기 부채: SOLARA 의 단기 자산( ₹8.0B )이 장기 부채( ₹1.7B ).


부채 대 자본 내역 및 분석

부채 수준: SOLARA 의 순부채 대 자기자본 비율( 105.8% )은 높음으로 간주됩니다.

부채 감소: SOLARA 의 부채 대 자기자본 비율은 지난 5년간 55.6% 에서 106.7% 로 증가했습니다.

부채 범위: SOLARA 의 부채는 영업 현금 흐름 ( 10.9% )에 의해 잘 갚지 않음입니다.

이자 보장: SOLARA 의 부채에 대한 이자 지급EBIT에 의해 잘 충당되었는지 판단할 데이터가 부족합니다.


대차 대조표


건강한 기업 발견하기